CRMP2 and voltage-gated ion channels: Potential roles in neuropathic pain

Lindsey A. Chew, Rajesh Khanna

Research output: Contribution to journalReview articlepeer-review


Neuropathic pain represents a significant and mounting burden on patients and society at large. Management of neuropathic pain, however, is both intricate and challenging, exacerbated by the limited quantity and quality of clinically available treatments. On this stage, dysfunctional voltage-gated ion channels, especially the presynaptic N-type voltage-gated calcium channel (VGCC) (Cav2.2) and the tetrodotoxin-sensitive voltage-gated sodium channel (VGSC) (Nav1.7), underlie the pathophysiology of neuropathic pain and serve as high profile therapeutic targets. Indirect regulation of these channels holds promise for the treatment of neuropathic pain. In this review, we focus on collapsin response mediator protein 2 (CRMP2), a protein with emergent roles in voltage-gated ion channel trafficking and discuss the therapeutic potential of targetting this protein.

Original languageEnglish (US)
JournalNeuronal Signaling
Issue number1
StatePublished - Mar 1 2018

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience


Dive into the research topics of 'CRMP2 and voltage-gated ion channels: Potential roles in neuropathic pain'. Together they form a unique fingerprint.

Cite this